Proteome analysis of haptoglobin in cerebrospinal fluid of neuromyelitis optica

Molecular Biology Reports

Volumn 37, Issue 3, 2010, Pages 1619-1625

  Bai, Shumei ^a   Liu, Shilian ^a   Guo, Xuxiao ^b   Qin, Zhaoyu ^c   Wang, Banqin ^a   Li, Xiaohong ^a   Qin, Yanjiang ^d  

^a SHANDONG UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c SHANDONG UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Cerebrospinal fluid; Haptoglobin; Neuromyelitis optica; Proteome

Indexed keywords

HAPTOGLOBIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; IMAGE ANALYSIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MYELOOPTIC NEUROPATHY; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN INTERACTION; SEPARATION TECHNIQUE; TWO DIMENSIONAL ELECTROPHORESIS; BIOLOGY; CEREBROSPINAL FLUID; COMPUTER PROGRAM; GENETICS; MASS SPECTROMETRY; NONPARAMETRIC TEST; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPTOGLOBINS; HUMANS; MALE; NEUROMYELITIS OPTICA; PROTEIN INTERACTION MAPPING; PROTEOMICS; SOFTWARE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STATISTICS, NONPARAMETRIC;

EID: 77951886497     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9574-7     Document Type: Article

References (21)

1. Argyriou AA, Makris N (2008) Neuromyelitis optica: A distinct demyelinating disease of the central nervous system. Acta Neurol Scand 118(4):209-217. doi:10.1111/j.1600-0404.2008.01002.x
2. Weinshenker BG, Wingerchuk DM (2008) Neuromyelitis optica: Clinical syndrome and the NMO-IgG autoantibody marker. Curr Top Microbiol Immunol 318:343-356. doi:10.1007/978-3-540- 73677-6-14
3. Zaffaroni M, The Italian Devic's Study Group (2004) Cerebrospinal fluid findings in Devic's neuromyelitis optica. Neurol Sci 25(4):368-370. doi:10.1007/s10072-004-0343-z
4. Yuan X, Desiderio DM (2003) Proteomics analysis of phosphotyrosylproteins in human lumbar cerebrospinal fluid. J Proteome Res 2(5):476-487. doi:10.1021/pr025589a
5. Wingerchuk DM, Hogancamp WF, O'Brien PC et al (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53(5):1107-1114
6. Yang Y, Liu S, Qin Z et al (2008) Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain-Barré Syndrome by a proteomical approach. Mole Biol Rep 36(4):677-682
7. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254. doi: 10.1016/0003-2697(76)90527-3
8. Liz MA, Gomes CM, Saraiva MJ et al (2007) ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. J Lipid Res 48(11):2385-2395. doi: 10.1194/jlr.M700158-JLR200
9. Ranganathan S, Williams E, Ganchev P et al (2005) Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem 95(5):1461-1471. doi: 10.1111/j.1471-4159.2005.03478.x
10. Pinholt M, Frederiksen JL, Andersen PS et al (2005) Apo E in multiple sclerosis and optic neuritis: The apoE-epsilon4 allele is associated with progression of multiple sclerosis. Mult Scler 11(5):511-515. doi:10.1191/1352458505ms1207oa
11. Gaillard O, Gervais A, Meillet D et al (1998) Apolipoprotein E and multiple sclerosis: A biochemical and genetic investigation. J Neurol Sci 158(2):180-186. doi:10.1016/S0022-510X(98) 00118-X
12. Sjogren M, Blomberg M, Jonsson M et al (2001) Neurofilament protein in cerebrospinal fluid: A marker of white matter changes. J Neurosci Res 66(3):510-516. doi:10.1002/jnr.1242
13. Miyazawa I, Nakashima I, Petzold A et al (2007) High CSF neurofilament heavy chain levels in neuromyelitis optica. Neurology 68(11):865-867. doi:10.1212/01.wnl.0000256820.264 89.17
14. Tseng CF, Lin CC, Huang HY et al (2004) Antioxidant role of human haptoglobin. Proteomics 4(8):2221-2228. doi:10.1002/ pmic.200300787
15. Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42(10):1589-1600
16. Chamoun V, Zeman A, Blennow K et al (2001) Haptoglobins as markers of blood-CSF barrier dysfunction: The findings in normal CSF. J Neurol Sci 182(2):117-121. doi:10.1016/S0022-510X(00) 00461-5
17. Rite I, Argüelles S, Venero JL et al (2007) Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration. J Neurosci Res 85(16):3607-3618. doi:10.1002/jnr. 21452
18. Mattila KM, Pirtilla T, Blennow K et al (1994) Altered blood- brain barrier function in Alzheimer's disease? Acta Neurol Scand 89:192-198. doi:10.1111/j.1600-0404.1994.tb05221.x
19. do Nascimento CO, Hunter L, Trayhurn P (2004) Regulation of haptoglobin gene expression in 3T3-L1 adipocytes by cytokines catecholamines and PPAR gamma. Biochem Biophys Res Commun 313(3):702-708. doi:10.1016/j.bbrc.2003.12.008
20. Wagner L, Gessl A, Baumgartner Parzer S et al (1996) Haptoglobin phenotyping by newly developed monoclonal antibodies. Demonstration of haptoglobin uptake into peripheral blood neutrophils and monocytes. J Immunol 156(5):1989-1996
21. Berkova N, Gilbert C, Goupil S et al (1999) TNF-induced haptoglobin release from human neutrophils: Pivotal role of the TNF p55 receptor. J Immunol 162(10):6226-6232